Skip to main content
ARWR logo

ARWR · Arrowhead Pharmaceuticals, Inc. · Analyst Estimates

Track ARWR — free
Market Cap
$6.75B
Shares
141.37M
Volume · Nov 16 844.9K Avg daily vol (3M) 1.92M

Analyst Estimates

Compare analyst forecasts for Arrowhead Pharmaceuticals, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Pull consensus estimates through the analyst estimates API or MCP →

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-11-15 03:25 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2027-09-30

Analyst estimates for FY ending 2027-09-30
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-6.46
-5.34
-3.91
12
-4.98
-4.98
-4.80
-4.87
6
6
— —
Revenue
USD
Publication date not stated
255.25M
306.65M
392.40M
9
— — — — — — — —

FY ending 2028-09-30

Analyst estimates for FY ending 2028-09-30
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-5.80
-2.95
0.14
10
-3.12
-3.12
-2.97
-2.95
2
2
1
2
Revenue
USD
Publication date not stated
320.00M
642.31M
1.45B
11
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-1.76
-1.51
-1.26
6
-1.37
-1.37
-1.34
-1.41
1
1
0
0
Revenue
USD
Publication date not stated
30.00M
45.14M
66.80M
6
— — — — — — — —

Q ending 2027-03-31

Analyst estimates for Q ending 2027-03-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-1.76
-1.47
-1.29
6
-1.30
-1.30
-1.33
-1.40
1
1
0
0
Revenue
USD
Publication date not stated
30.00M
45.49M
79.70M
5
— — — — — — — —
Key facts CIK 879407 CUSIP 04280A100 13F (30d) 365 filings 343 filers Visit website Investor relations